- The Tests They Are A-Changing: FDA Takes Action on Biosimilars November 4, 2025
 - California’s New Allergen-Disclosure Law: A Sign of Things to Come? October 31, 2025
 - Onshoring Drug Manufacturing: Insights from FDA’s PreCheck Initiative and Public Meeting October 28, 2025
 - You’ve Got Mail, and Twice the Time to Respond! Two Device Companies Find Themselves with 30 Business Days to Respond to FDA’s Warning Letters October 27, 2025
 - Bring Out Your Meds! Bring Out Your Meds! October 22, 2025
 
- Big Molecule Watch Blog
 - Bloomberg BNA Health Care Blog
 - Drug and Device Law Blog
 - Eye on FDA
 - FDA Matters
 - Harvard Law Bill of Health
 - IN VIVO Blog
 - Internet Drug News.com
 - Lachman Consultants Blog
 - Medical Devices Today
 - Orange Book Blog
 - The Orange Book Insights Blog
 - Pharma IQ
 - Pharmalot
 - SCOTUS Blog
 - The Volokh Conspiracy
 - WLF Legal Pulse
 
- Advertising and Promotion (Federal Trade Commission)
 - Advertising and Promotion (OPDP)
 - Animal Drugs and Feeds
 - Biosimilars
 - Cannabis
 - cGMP Compliance
 - Consumer Product Safety Commission
 - Controlled Substances
 - Cosmetics
 - COVID19
 - Current Affairs
 - Dietary Supplements
 - Drug Development
 - Drug Enforcement Administration
 - Enforcement
 - FDA News
 - Foods
 - Foods and Dietary Supplements
 - Fraud and Abuse
 - Government Pricing
 - Hatch-Waxman
 - Health Care
 - Health Privacy
 - Import/Export
 - In Vitro Diagnostic Devices
 - Jobs
 - Medical Devices
 - Miscellaneous
 - Orphan Drugs
 - OTC Drugs and Cosmetics
 - Prescription Drugs and Biologics
 - Product Jurisdiction and Combination Products
 - Reimbursement
 - Tissue Products
 - Tobacco
 - Uncategorized
 
Access to HPM’s Free FDA Enforcement Webinar Now Available!
May 1, 2025Thanks to everyone who joined us today. We are excited that you were able to join us for our discussion of enforcement under the new FDA. We hope you enjoyed a lively conversation. We appreciated all of the questions we received from the audience. If you were unable to join, you can still watch our recorded webinar here.
Stay tuned for news on future webinars this summer!
Categories: Enforcement
Search FDA Law Blog
Subscribe
Latest Tweets
Tweets by @fdalawblogAwards & Honors
- Best Lawyers in America® – 2025
 - Ranked in Chambers USA – 2024
 
- The Tests They Are A-Changing: FDA Takes Action on Biosimilars November 4, 2025
 - California’s New Allergen-Disclosure Law: A Sign of Things to Come? October 31, 2025
 - Onshoring Drug Manufacturing: Insights from FDA’s PreCheck Initiative and Public Meeting October 28, 2025
 - You’ve Got Mail, and Twice the Time to Respond! Two Device Companies Find Themselves with 30 Business Days to Respond to FDA’s Warning Letters October 27, 2025
 - Bring Out Your Meds! Bring Out Your Meds! October 22, 2025
 
- Big Molecule Watch Blog
 - Bloomberg BNA Health Care Blog
 - Drug and Device Law Blog
 - Eye on FDA
 - FDA Matters
 - Harvard Law Bill of Health
 - IN VIVO Blog
 - Internet Drug News.com
 - Lachman Consultants Blog
 - Medical Devices Today
 - Orange Book Blog
 - The Orange Book Insights Blog
 - Pharma IQ
 - Pharmalot
 - SCOTUS Blog
 - The Volokh Conspiracy
 - WLF Legal Pulse
 
- Advertising and Promotion (Federal Trade Commission)
 - Advertising and Promotion (OPDP)
 - Animal Drugs and Feeds
 - Biosimilars
 - Cannabis
 - cGMP Compliance
 - Consumer Product Safety Commission
 - Controlled Substances
 - Cosmetics
 - COVID19
 - Current Affairs
 - Dietary Supplements
 - Drug Development
 - Drug Enforcement Administration
 - Enforcement
 - FDA News
 - Foods
 - Foods and Dietary Supplements
 - Fraud and Abuse
 - Government Pricing
 - Hatch-Waxman
 - Health Care
 - Health Privacy
 - Import/Export
 - In Vitro Diagnostic Devices
 - Jobs
 - Medical Devices
 - Miscellaneous
 - Orphan Drugs
 - OTC Drugs and Cosmetics
 - Prescription Drugs and Biologics
 - Product Jurisdiction and Combination Products
 - Reimbursement
 - Tissue Products
 - Tobacco
 - Uncategorized